Quinoline derivatives as neuropeptide y antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/04 (2006.01) A61K 31/4709 (2006.01) A61P 3/04 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) C07D 401/12 (2006.01)

Patent

CA 2460865

Compounds of formula (I), as well as pharmaceutically acceptable salts and esters thereof, wherein R1, R2, R3, A1 and A2 have the significance given in claim 1, can be used in the form of pharmaceutical preparations for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders and obesity.

L'invention concerne des composés correspondant à la formule (I), ainsi que des sels et des esters pharmaceutiquement acceptables de ceux-ci. Dans ladite formule (I), R?1¿, R?2¿, R?3¿, A?1¿ et A?2¿ correspondent à la définition donnée dans la revendication 1. Ces composés, leurs sels et esters pharmaceutiquement acceptables peuvent être utilisés sous la forme de préparations pharmaceutiques pour le traitement ou la prévention de l'arthrite, de maladies cardio-vasculaires, du diabète, de l'insuffisance rénale, des troubles de l'alimentation et de l'obésité.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Quinoline derivatives as neuropeptide y antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline derivatives as neuropeptide y antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives as neuropeptide y antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1722832

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.